| Literature DB >> 26702261 |
Péter Diós1, Tivadar Pernecker1, Sándor Nagy1, Szilárd Pál1, Attila Dévay1.
Abstract
The object of the present study is to evaluate the effect of application of low-substituted hydroxypropyl cellulose (L-HPC) 11 and B1 as excipients promoting floating in gastroretentive tablets. Directly compressed tablets were formed based on experimental design. Face-centred central composite design was applied with two factors and 3 levels, where amount of sodium alginate (X 1) and L-HPC (X2 ) were the numerical factors. Applied types of L-HPCs and their 1:1 mixture were included in a categorical factor (X 3). Studied parameters were floating lag time, floating time, floating force, swelling behaviour of tablets and dissolution of paracetamol, which was used as a model active substance. Due to their physical character, L-HPCs had different water uptake and flowability. Lower flowability and lower water uptake was observed after 60 min at L-HPC 11 compared to L-HPC B1. Shorter floating times were detected at L-HPC 11 and L-HPC mixtures with 0.5% content of sodium alginate, whereas alginate was the only significant factor. Evaluating results of drug release and swelling studies on floating tablets revealed correlation, which can serve to help to understand the mechanism of action of L-HPCs in the field development of gastroretentive dosage forms.Entities:
Keywords: Disintegration; Floating force; Floating tablets; Gastroretentive; Low substituted hydroxypropyl cellulose; Sodium alginate
Year: 2014 PMID: 26702261 PMCID: PMC4669424 DOI: 10.1016/j.jsps.2014.09.001
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.330
Levels and real values of experimental design.
| Levels of factors | −1 | 0 | 1 |
| Concentration of sodium alginate, | 0.50 | 17.82 | 35.15 |
| Concentration of L-HPCs, | 0.50 | 12.75 | 25.00 |
Experimental layout of categorical face-centred central composite design(X).
| Exp. No. | Sodium alginate | L-HPC 11 |
|---|---|---|
| PFS01 | −1 | −1 |
| PFS02 | 1 | −1 |
| PFS03 | −1 | 1 |
| PFS04 | 1 | 1 |
| PFS05 | −1 | 0 |
| PFS06 | 1 | 0 |
| PFS07 | 0 | −1 |
| PFS08 | 0 | 1 |
| PFS09 | 0 | 0 |
| Exp. No. | Sodium alginate | L-HPC B1 |
| PFS10 | −1 | −1 |
| PFS11 | 1 | −1 |
| PFS12 | −1 | 1 |
| PFS13 | 1 | 1 |
| PFS14 | −1 | 0 |
| PFS15 | 1 | 0 |
| PFS16 | 0 | −1 |
| PFS17 | 0 | 1 |
| PFS18 | 0 | 0 |
| Exp. No. | Sodium alginate | L-HPC 11/B1 (1:1) |
| PFS19 | −1 | −1 |
| PFS20 | 1 | −1 |
| PFS21 | −1 | 1 |
| PFS22 | 1 | 1 |
| PFS23 | −1 | 0 |
| PFS24 | 1 | 0 |
| PFS25 | 0 | −1 |
| PFS26 | 0 | 1 |
| PFS27 | 0 | 0 |
Figure 1Structure of standard vessel and filtering plate for floating force test.
Figure 2Microscopic snapshots of (a) L-HPC 11 and (b) L-HPC B1 particles.
Figure 3Wettability of L-HPC 11 and L-HPC B1 in distilled water and in 0.1 M HCl.
Total wettability of L-HPC 11 and L-HPC B1.
| Total wettability of 50 mg L-HPCs | In distilled water (mg) | In 0.1 M HCl (mg) |
|---|---|---|
| L-HPC 11 | 483.7 ± 22.8 | 451.0 ± 17.4 |
| L-HPC B1 | 522.7 ± 36.6 | 480.0 ± 39.6 |
Flow characteristics of L-HPC 11 and L-HPC B1.
| Carr index | Hausner ratio | Angle of repose (°) | |
|---|---|---|---|
| L-HPC 11 | 22.91 ± 0.32 | 1.24 ± 0.04 | 48.77 ± 1.67 |
| L-HPC B1 | 19.05 ± 2.31 | 1.19 ± 0.02 | 39.24 ± 0.86 |
Data of floating lag time (t) and floating time (t).
| Exp. No. | ||
|---|---|---|
| PFS01 | 6.44 ± 5.19 | 21.70 ± 4.56 |
| PFS02 | 343.00 ± 28.99 | 240.00 ± 0.00 |
| PFS03 | 0.00 ± 0.00 | 7.13 ± 0.47 |
| PFS04 | 507.16 ± 100.35 | 240.00 ± 0.00 |
| PFS05 | 0.00 ± 0.00 | 3.91 ± 0.28 |
| PFS06 | 107.16 ± 75.77 | 240.00 ± 0.00 |
| PFS07 | 109.20 ± 89.32 | 240.00 ± 0.00 |
| PFS08 | 16.69 ± 1.58 | 240.00 ± 0.00 |
| PFS09 | 520.30 ± 20.79 | 240.00 ± 0.00 |
| PFS10 | 16.02 ± 6.58 | 28.63 ± 1.08 |
| PFS11 | 356.55 ± 47.07 | 240.00 ± 0.00 |
| PFS12 | 0.00 ± 0.00 | 15.51 ± 2.96 |
| PFS13 | 230.16 ± 11.87 | 240.00 ± 0.00 |
| PFS14 | 0.00 ± 0.00 | 15.25 ± 1.89 |
| PFS15 | 507.67 ± 161.30 | 240.00 ± 0.00 |
| PFS16 | 273.45 ± 156.64 | 240.00 ± 0.00 |
| PFS17 | 180.00 ± 51.64 | 240.00 ± 0.00 |
| PFS18 | 106.14 ± 24.18 | 240.00 ± 0.00 |
| PFS19 | 25.77 ± 6.53 | 35.74 ± 3.05 |
| PFS20 | 238.16 ± 13.25 | 240.00 ± 0.00 |
| PFS21 | 13.87 ± 3.25 | 17.23 ± 1.25 |
| PFS22 | 417.22 ± 18.12 | 240.00 ± 0.00 |
| PFS23 | 8.10 ± 2.62 | 13.34 ± 0.34 |
| PFS24 | 330.33 ± 27.79 | 240.00 ± 0.00 |
| PFS25 | 307.71 ± 174.70 | 240.00 ± 0.00 |
| PFS26 | 344.00 ± 29.70 | 240.00 ± 0.00 |
| PFS27 | 184.00 ± 24.64 | 240.00 ± 0.00 |
Figure 4Floating force of (a) PFS03 (25.0% L-HPC 11, 0.5% sodium alginate) and (b) PFS04 (25.0% L-HPC 11, 35.15% sodium alginate).
Figure 5Release of paracetamol from EFTs containing L-HPC 11.
Figure 6Influence of swelling capability on dissolution comparing PFS22 (25.0% L-HPC 11/B1, 35.15% sodium alginate) and PFS25 (0.5% L-HPC 11/B1, 17.82% sodium alginate).